Alliance for Biomedical Research in Europe
The Alliance for Biomedical Research in Europe was founded in 2010. Its principal goals and objectives are to promote the best interests and values of research across all medical disciplines in Europe, in those general areas where common interest is identified. The alliance particularly seeks to facilitate and improve biomedical research in Europe, develop a framework for better training and mobility of young researchers in Europe and improve public understanding of medical science in Europe. EULAR joined the alliance in 2011 and actively participates in its activities.
Read more about the BioMed Alliance Survey on H2020 and key recommendations on H2020 midterm evaluation by clicking here.
Read the BioMed Alliance Position Statement in support of the EU Directive on Animal Research (2010/63/EU) by clicking here.
Innovative Medicine Initiative (IMI)
The IMI represents a new approach to research funding at European level. Such Joint Technology Initiatives (JTI) and European Technology Platforms were designed to create private-public partnerships (PPP) for research and development. In the case of the IMI, both the European Union through its 7th Research Framework Programme and the pharmaceutical industry through its umbrella organisation EFPIA provide funding for projects in selected areas.
Together with other leading medical societies, EULAR contributed to the establishment of IMI. The IMI research agenda includes an overall section on inflammatory diseases, which includes arthritis and rheumatoid arthritis.